Drug-Induced Liver Injury After Zoledronic Acid Infusion and Literature Review

Zoledronic acid, a bisphosphonate, is commonly used to treat and prevent osteoporosis. Here we report a rare case of acute hepatotoxicity after zoledronic acid infusion in a 50-year-old female patient with no preexisting liver disease taking anastrozole and abemaciclib. Only a few hours after her infusion, the patient developed severe body aches, nausea, and abdominal bloating. Laboratory tests revealed an acute liver injury. Acute viral hepatitis workup was negative, and she was subsequently diagnosed with a hepatocellular drug-induced liver injury. Her transaminitis downtrended over the following day and normalized after 11 days. Given this rarely reported side effect, there is a paucity of evidence to guide treatment decisions. The goal of this case report is to increase awareness of this adverse effect, especially among patients taking other potentially hepatotoxic drugs.

Authors

Institutions

Publication Details

Journal
JCEM Case Reports
Published
2025-03-17
DOI
https://doi.org/10.1210/jcemcr/luaf046
Primary Topic
Bone health and treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Drug-Induced Liver Injury After Zoledronic Acid Infusion and Literature Review

Huifang Lu, Christopher Boldt, Pooja Prasad
JCEM Case Reports
Bone health and treatments
article

Drug-Induced Liver Injury After Zoledronic Acid Infusion and Literature Review

Huifang Lu, Christopher Boldt, Pooja Prasad
article en

Abstract

Zoledronic acid, a bisphosphonate, is commonly used to treat and prevent osteoporosis. Here we report a rare case of acute hepatotoxicity after zoledronic acid infusion in a 50-year-old female patient with no preexisting liver disease taking anastrozole and abemaciclib. Only a few hours after her infusion, the patient developed severe body aches, nausea, and abdominal bloating. Laboratory tests revealed an acute liver injury. Acute viral hepatitis workup was negative, and she was subsequently diagnosed with a hepatocellular drug-induced liver injury. Her transaminitis downtrended over the following day and normalized after 11 days. Given this rarely reported side effect, there is a paucity of evidence to guide treatment decisions. The goal of this case report is to increase awareness of this adverse effect, especially among patients taking other potentially hepatotoxic drugs.

JCEM Case ReportsVol. 3(4)
The University of Texas MD Anderson Cancer Center (US), Baylor College of Medicine (US), Baylor School (US)
Good health and well-being
Openalex Percentile: Top 92%
Bone health and treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.